Finding the Next Treatments for Psychiatric and Neurological Disorders

Our Company Develops the Next Generation of Drug Efficacy Predictions for Psychiatric and Neurological Disorders.

Using a Unique Combination of Technologies, We Created a Novel, Scalable, and Cost-Effective Platform for Diagnostics, and Drug Testing, Screening, and Discovery

1 Billion

People are diagnosed with psychiatric or neurological disorders

13% increase

Of neurological and psychiatric disorders in the last decade!

Only 5

New drugs were approved in the last 20 years!

We Have a Way to Test, Screen, and Develop Personalized Treatments for Neuro-Psychiatric Disorders with Predictions of Clinical Success

Our leadership

We Have a Team of Exceptional People with a Rich and Successful Record in Science, Technology, Entrepreneuring, and Business Management. Our R&D Team Comprises Talented Ph.D. Scientists with a Multidisciplinary Background, Including in the Fields of Drug Development, Neuroscience, Developmental Biology, Computer Science, Chemistry, and Physics.

Business Focus

Over 95% of the Pre-Clinically Developed Drugs Fail in the Translation to the Clinic, Causing Billions of Dollars in Losses for Pharma Companies. 

Our Technology Enables to Test, Screen, and Develop New Treatments for Neuro-Psychiatric Disorders with Significantly Higher Success Chances of Being Translated to the Clinic.

Together with Hadassah Hospital in Jerusalem, we are currently validating our drug discovery platform using samples of 200 patients

Skip to content